ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 25 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $63,000 | -25.9% | 31,410 | 0.0% | 0.00% | – |
| Q4 2021 | $85,000 | -37.0% | 31,410 | 0.0% | 0.00% | – |
| Q3 2021 | $135,000 | +68.8% | 31,410 | 0.0% | 0.00% | – |
| Q2 2021 | $80,000 | +5.3% | 31,410 | 0.0% | 0.00% | – |
| Q1 2021 | $76,000 | +137.5% | 31,410 | +68.8% | 0.00% | – |
| Q4 2020 | $32,000 | – | 18,612 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 38,982 | $200,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 802 | $5,000 | 0.00% |
| UBS Group AG | 2,723 | $14,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11,775 | $60,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 250 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,162 | $138,000 | 0.00% |
| MORGAN STANLEY | 545 | $3,000 | 0.00% |
| BlackRock Inc. | 205,684 | $1,053,000 | 0.00% |